Eunice SN 100mg/15mg Tablet

Eunice SN 100mg/15mg Tablet brings two different ingredients into one tablet. Nimesulide is a unique NSAID with a basic sulfonanilide chemical structure (a chemical shape similar to sulfa-type drugs). It reduces pain, fever and inflammation by blocking the formation of prostaglandins, the body chemicals that drive pain and swelling, and it acts with relative specificity on COX-2, the cyclooxygenase form most closely tied to pain pathways, while sparing COX-1, which protects the stomach lining and supports platelet function. It also has a rapid onset of action. In countries where it remains available, nimesulide is generally limited to mild-to-moderate acute pain, taken as 100 mg twice daily for no more than 15 days, and it is considered contraindicated in children.

Serratiopeptidase is a proteolytic enzyme isolated from the non-pathogenic bacterium Serratia E15 found in silkworms. It is prescribed across surgery, orthopaedics, ENT, gynaecology and dentistry for its anti-inflammatory, anti-swelling and pain-supportive effects. Research describes it as reducing capillary permeability driven by histamine, bradykinin and serotonin, breaking down abnormal exudates and helping the body clear decomposed products through blood and lymph. It is also reported to dissolve dead and damaged tissue left behind by the healing response without harming living tissue.

Because this combination is a short-term pain and inflammation medicine, it must be taken exactly as prescribed and only for the duration the doctor sets. Nimesulide has a well-established link to clinically apparent liver injury, which can occasionally be severe, so any nausea, dark urine, yellowing of the eyes or unusual tiredness during treatment should be reported without delay. People with kidney, heart or stomach problems and those on blood thinners should discuss the full picture with their doctor before this combination is prescribed.

Each tablet contains Nimesulide 100 mg and Serratiopeptidase 10 mg. Nimesulide is the active anti-inflammatory and analgesic component. Serratiopeptidase is a large protein molecule (about 60 kilodaltons, i.e. 60,000 protein units) with proteolytic (protein-digesting) activity, classified under enzyme commission number EC 3.4.24.40, that adds an enzyme-based anti-swelling action. Read the label on your own strip, because strength and manufacturer can vary.

• Acute pain relief - Nimesulide is used, in the countries where it is available, for mild-to-moderate acute pain, and it has analgesic, antipyretic and anti-inflammatory activity.
• Swelling and inflammation - Serratiopeptidase is used in surgical, orthopaedic, ENT, gynaecological and dental practice for its anti-inflammatory and anti-swelling effects.
• Painful inflammatory conditions - The combination has been marketed in India for painful inflammatory conditions such as musculoskeletal and joint pain, dental pain and swelling after injury or surgery.
• Infection-related swelling support - Doctors may sometimes use it around the treatment of swelling associated with infections, as serratiopeptidase is reported to reduce the thickness of mucus and support clearance of bronchopulmonary secretions.

1. Dual action on pain and swelling - Nimesulide blocks prostaglandin formation through COX-2 inhibition while serratiopeptidase works on exudates, capillary permeability and tissue repair, so the two ingredients act on different parts of the inflammatory process.
2. Rapid onset of relief - Nimesulide has a rapid onset of action, and serratiopeptidase reaches peak blood levels about one hour after oral intake.
3. Enzyme-based anti-swelling support - Serratiopeptidase breaks down abnormal exudates and dead tissue by-products without harming living tissue, which supports recovery after injury or surgery.
4. COX-2 preference with less platelet effect - Nimesulide's relative COX-2 selectivity means it has relatively scant effect on platelet function compared with COX-1-dominant NSAIDs, though it still carries the serious risks of the NSAID class.
5. Single tablet for the short term - One tablet delivers both components together, simplifying a short course prescribed for acute pain and inflammation.

Common Side Effects (Usually Mild and may lessen with continued use)

• Headache, dizziness or somnolence (sleepiness)
• Stomach upset, nausea or abdominal discomfort
• Diarrhoea
• Peripheral edema (swelling of the limbs)
• Transient rises in liver enzymes on blood tests
• Upset stomach or belly pain linked to the enzyme component
• Hypersensitivity or skin reactions in sensitive people

Serious Side Effects (Seek Urgent Medical Attention)

• Signs of clinically apparent liver injury: yellowing of eyes or skin (jaundice), dark urine, nausea with loss of appetite, severe tiredness or pain in the upper right belly. Nimesulide is a well-established cause of acute liver injury, which can be severe and can lead to acute liver failure.
• Gastrointestinal ulceration, bleeding or perforation: vomiting blood, black or tarry stools, or severe stomach pain.
• Serious cardiovascular events: increased risk of myocardial infarction and stroke with NSAIDs.
• Renal dysfunction: reduced urine output, swelling of legs, or unusual weakness.
• Severe allergic reactions: wheezing, chest tightness, trouble breathing or swallowing, swelling of the face, lips, tongue or throat.
• Severe skin reactions including exfoliative dermatitis and Stevens Johnson syndrome.
• Exacerbation of asthma.

• Take the tablet exactly as your doctor has prescribed, at the dose and for the duration set out in your prescription.
• Swallow the tablet whole with a full glass of plain water. Do not crush, chew or break it.
• Take it after food, because this combination can irritate an empty stomach.
• Use it for the short term only. Where the medicine remains available, nimesulide is limited to no more than 15 days of use, and chronic therapy is not generally recommended.
• Do not change the dose, and do not continue beyond the days your doctor has set.
• If the tablet is part of a strip with a printed date schedule, follow the schedule so you do not skip or repeat a dose.
• Take it at the same time or times each day so the effect stays steady.
• Keep the tablet intact: crushing or chewing destroys the tablet's release form and can increase local stomach irritation.
• Do not take two tablets to make up for a forgotten dose, and do not double the dose to speed up relief.
• Keep a steady gap of about 12 hours between the two doses of the day.
• Avoid alcohol while you are on this medicine.

Nimesulide: Like other NSAIDs, nimesulide inhibits the enzyme cyclo-oxygenase (COX), which blocks the formation of proinflammatory prostaglandins that are central to pain and inflammatory pathways. Unlike most conventional NSAIDs, nimesulide has a relative specificity for COX-2, the form most closely related to pain pathways, while COX-1 is the form that largely protects the gastric lining and drives platelet function. Nimesulide reversibly inhibits the formation of prostaglandin E2 both at the site of inflammation and along the ascending pain pathways, including the spinal cord's transmission of pain impulses, and it reduces the concentration of short-lived prostaglandin H2 from which prostaglandin E2 is formed. The fall in prostaglandin E2 lowers the activation of EP-type prostanoid receptors, which shows up as analgesic and anti-inflammatory effects. Nimesulide also has actions beyond cyclo-oxygenase that may add to its pain-relieving effect.

Serratiopeptidase: This enzyme's exact molecular mechanism is not fully known, but it is reported to have a higher affinity for cyclooxygenase (COX-I and COX-II), the key enzyme family behind inflammatory mediators such as interleukins, prostaglandins and thromboxanes. It reduces capillary permeability induced by histamine, bradykinin and serotonin, breaks down abnormal exudates and proteins, and helps their absorption through blood and lymph. It modifies cell-surface adhesion molecules that draw immune cells into damaged tissue, promotes wound healing and repair, and can restore the temperature of an inflamed area to normal. Because serratiopeptidase does not block the lipoxygenase (LOX) pathway, it is described as indirectly supporting the natural resolution of inflammation. Taken orally, it is absorbed unchanged into the systemic circulation, penetrates inflamed tissue in high concentration and reaches peak levels in about one hour.

Together: Nimesulide stops the chemical signals that produce pain and swelling, while serratiopeptidase clears inflammatory debris and supports tissue repair, which is the rationale behind combining the two.

• Take it after food with a full glass of plain water.
• Swallow whole; never crush, chew or split the tablet.
• Keep the course short: no more than the number of days your doctor has set, and never beyond 15 days for nimesulide-based treatment.
• Report dark urine, yellow eyes, nausea with loss of appetite or unusual tiredness to your doctor immediately; these can be early signs of liver injury.
• Do not combine it with other NSAIDs or aspirin, which raise bleeding risk.
• Tell your surgeon or dentist you are taking this medicine before any procedure.
• Skip alcohol for the whole course.
• Keep the strip away from heat, moisture and small children.
• Do not start or stop any other medicine without asking your doctor while you are on this combination.

• This is a short-course medicine for acute pain. Long-term or repeated self-directed courses are not appropriate.
• Nimesulide carries the NSAID class risks of gastrointestinal ulceration, bleeding and perforation, serious cardiovascular events, renal dysfunction and hypersensitivity reactions, including anaphylaxis.
• Tell your doctor before any surgery or diagnostic test that you are taking this combination, because serratiopeptidase can increase bleeding risk alongside blood-thinning medicines.
• If you have ever had a liver reaction to any medicine, mention it before starting.
• Recurrence of liver injury on rechallenge with nimesulide has been reported, so it should be avoided once a liver reaction has occurred.
• Use caution after nimesulide-related liver injury with sulfonamide-related medicines such as celecoxib or zonisamide.
• Keep the doctor informed of all other tablets you take, including herbal products, so interactions can be checked.

• Store below 25-30°C (77-86°F), in a cool, dry place, away from direct sunlight and away from sources of heat and damp such as kitchens and bathrooms.
• Keep the tablets in their original strip until the dose is due; the blister protects them from light and moisture.
• Keep the pack out of reach of children and pets. A swallowed tablet can cause serious harm to a child.
• Do not use tablets that are past their expiry date, discoloured or damaged, and do not store them in another container that can confuse the contents.
• Return unused or expired tablets to a pharmacist for safe disposal instead of throwing them in household waste where children or animals can reach them.

• Alcohol: avoid completely during the course. Nimesulide is extensively metabolised by the liver, and combining it with alcohol adds risk to an organ already under strain from the medicine.
• Food: take the tablet after a meal to lower the chance of stomach irritation. A steady pattern of meals and doses keeps absorption predictable.
• Irritating drinks: very strong tea, coffee or acidic drinks on an already NSAID-irritated stomach can add to discomfort; prefer plain water with the dose.
• Herbal or unlabelled liver remedies: do not add herbal tonics or unverified supplements during the course without telling your doctor, because nimesulide's main safety concern is liver injury and mixed products make monitoring harder.

• Other NSAIDs, aspirin, ibuprofen or naproxen: taking these alongside this combination increases the risk of bleeding. Do not stack painkillers without your doctor's instruction.
• Blood thinners such as warfarin, heparin or enoxaparin: take extra care; the combination can add to bleeding risk. Any bruising, bleeding gums or dark stools should be reported at once.
• Clot-dissolving medicines such as alteplase, reteplase or streptokinase: take extra care, because the enzyme component may add to bleeding risk in people on these drugs.
• Sulfonamide-related medicines (for example celecoxib, zonisamide) and sulfonamide antibiotics: caution is advised after any nimesulide-related liver injury because of nimesulide's sulfonanilide structure.
• Antibiotics such as ampicillin, cephalexin, minocycline or cefotiam: serratiopeptidase has been shown to enhance the activity of several antibiotics, so tell your doctor if you are on an antibiotic course.
• Blood pressure and heart medicines: NSAIDs can cause salt and water retention, so tell your doctor if you take medicine for blood pressure, heart failure or swelling.
• Other liver-processed medicines: because nimesulide is metabolised by the liver and has a well-established link to liver injury, your doctor will weigh any other medicine with liver toxicity against the short course.

• Liver disease or previous liver injury: avoid. Nimesulide is a well-established cause of clinically apparent liver injury, with reported overall mortality of 10 to 20 percent among jaundiced cases.
• Active peptic ulcer or GI bleeding: avoid. NSAIDs carry a risk of gastrointestinal ulceration, bleeding and perforation.
• Kidney impairment: caution. NSAIDs can cause renal dysfunction and can worsen pre-existing kidney disease.
• Heart disease and stroke risk: caution. NSAIDs carry an increased risk of serious cardiovascular events, including myocardial infarction and stroke.
• Bleeding disorders: caution. The serratiopeptidase component adds bleeding risk, and people with bleeding problems are specifically advised to check with their doctor first.
• Asthma: caution, because NSAIDs can exacerbate asthma.
• History of Stevens Johnson syndrome: caution with serratiopeptidase-containing products, as severe skin reactions are listed among the cautions.
• Pregnancy and planned surgery: see the Safety Advice section; both need a direct conversation with the doctor before the tablet is taken.

Daily dose - Where the combination remains available, nimesulide is generally limited to mild-to-moderate acute pain at a recommended adult dose of 100 mg twice daily, which matches one tablet of this combination twice a day and a maximum of 200 mg of nimesulide per 24 hours. Treatment is limited to no more than 15 days, and chronic therapy is not generally recommended. The serratiopeptidase component supplies 10 mg per tablet. Your doctor's prescribed dose and duration always take priority; never increase the dose, take it more often, or continue it on your own because the pain has not fully settled.

Overdose - Taking more tablets than prescribed will not improve pain relief, but it raises the risk of severe stomach irritation, liver injury and kidney problems. Warning signs after an overdose can include severe dizziness or sleepiness, vomiting, severe stomach or upper abdominal pain, yellowing of the eyes, dark urine or fainting. If an overdose is suspected, go to the nearest emergency department or contact a poison control centre immediately, and carry the tablet strip with you so the treating team can see exactly what was taken. Do not wait for symptoms to settle on their own.

Take the missed dose as soon as you remember, unless it is nearly time for the next one. In that case, skip the missed dose and continue with your regular schedule. Never take two tablets together to make up for the missed one, and never shorten the gap between doses. If you find you have missed more than one dose, tell your doctor before restarting, because the prescribed duration should not be extended by the delay.

Seek urgent medical attention if you notice any of the following:

• Yellowing of the eyes or skin, dark urine, pale stools, or persistent nausea and extreme tiredness, which can signal liver injury
• Vomiting blood, or black tarry stools
• Wheezing, chest tightness, swelling of the face, lips, tongue or throat, or trouble breathing or swallowing
• A spreading rash, blisters, or peeling skin
• Severe stomach pain that does not settle
• Less urine than usual, or new swelling of the legs
• Chest pain, weakness on one side of the body, or slurred speech
• Unusual bruising or bleeding, including heavy or unexpected menstrual bleeding
• Fever with chills or any sign of infection while on treatment

This article is for informational purposes only and is not a substitute for professional medical advice. Always consult a registered medical practitioner before starting, stopping, or changing any medicine.